![Jay Luly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Luly
Vorstandsvorsitzender bei
ENANTA PHARMACEUTICALS, INC.
Vermögen: 11 Mio $ am 31.05.2026
Profil
Jay R.
Luly is President, Chief Executive Officer & Director at Enanta Pharmaceuticals, Inc. since 2003.
Former positions include Director at Artesian Therapeutics, Inc., Senior Vice President-Drug Discovery & Pre-Clinical Development at Abbott Laboratories from 1983 to 1997, Senior Vice President-Research & Development Operations at Millennium Pharmaceuticals, Inc., Senior Vice President-Drug Discovery & Preclinical Development at LeukoSite, Inc., and Trustee at The Boston Biomedical Research Institute.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.02.2026 | 871’871 ( 3% ) | 11 Mio $ | 31.05.2026 |
Aktive Positionen von Jay Luly
| Unternehmen | Position | Beginn |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.07.2003 |
Ehemalige bekannte Positionen von Jay Luly
| Unternehmen | Position | Ende |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Technik-/Wissenschafts-/F&E-Leiter | - |
The Boston Biomedical Research Institute | Direktor/Vorstandsmitglied | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Direktor/Vorstandsmitglied | - |
Ausbildung von Jay Luly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Boston Biomedical Research Institute |
